Inspire Advisors, LLC Sage Therapeutics, Inc. Transaction History

Inspire Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$40.65 - $59.54 $55,405 - $81,153	1,363 Added 7.49%	19,553 $919,000
Q1 2023 Apr 24, 2023	BUY	$37.27 - $46.57 $677,941 - $847,108	18,190 New	18,190 $763,000
Q2 2022 Aug 10, 2022	SELL	$27.52 - $37.99 $341,936 - $472,025	-12,425 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$30.71 - $45.71 $381,571 - $567,946	12,425 New	12,425 $411,000

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Advisors, LLC with notifications on news.